What side effects did patients have in this study?
The most common side effects, which happened in more than 10 out of 100 patients (10%) in either
treatment group, are shown below:
- Headache: 26 out of 97 patients (27%)
- Cough: 5 out of 97 patients (5%)
- Head cold: 21 out of 97 patients (22%)
- Common cold: 18 out of 97 patients (19%)
- Ravulizumab: 20% of patients in both treatment groups had a side effect that was thought by the study doctor to be related to the study treatment.

What serious side effects did patients have in this study?
Overall, 12 out of 195 patients (6%) had a serious side effect.
- RAVULIZUMAB: 4 out of 97 patients (4%)
- ECULIZUMAB: 8 out of 98 patients (8%)
The most commonly reported serious side effect was a fever. 3 patients experienced this: all 3 patients were on eculizumab.